<DOC>
	<DOCNO>NCT02908152</DOCNO>
	<brief_summary>The purpose study investigate effect curcumin supplement metabolic factor hepatic fibrosis nonalcoholic fatty liver patient type 2 diabetes . Subjects participate 3 month , two group , randomize intervention , one group ( n=25 ) take 1.5g/d curcumin group ( n=25 ) take placebo compare difference outcomes two group .</brief_summary>
	<brief_title>Curcumin Supplement Nonalcoholic Fatty Liver Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Patient diagnose type 2 diabetes base ADA definition take oral antidiabetic drug ; CAP score &gt; 263 . Taking kind antibiotic two week recruitment ; History alcohol consumption ; pregnancy lactation ; Professional athlete ; Other liver disease ( viral/etc ) ; High dose synthetic estrogen , methotrexate , amiodarone , steroid , chloroquine , immunosuppressive drug ; A history Cardiovascular disease ; Renal disease , Celiac disease , Cirrhosis ; History Upper GI surgery ; A history hypothyroidism Cushing 's syndrome ; History drug dependence ; Body mass index ( BMI ) ≥35 kg/m2 ; A restrictive diet weight change ≥ 5 kg 3months prior study ; Any change treatment oral hypoglycemic ; anti hypertensive antilipid agent study ; Use weight loss medication .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>